French recommendations on multi-gene panel testing in renal cell carcinoma

Unlike hereditary predisposition to breast or colon cancer, hereditary renal cancer predispositions are rare syndromes and risk estimates are lacking for most of them. Prospective studies are needed to improve our knowledge. The GGC-PREDIR experts retained 12 genes for inclusion in the NGS MGP for renal cancer patients. However, the panel will be expanded on the basis of regularly updated data from the medical literature.

Authors

Institutions

Publication Details

Journal
European Journal of Medical Genetics
Published
2025-11-20
DOI
https://doi.org/10.1016/j.ejmg.2025.105062
Primary Topic
Renal cell carcinoma treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

French recommendations on multi-gene panel testing in renal cell carcinoma

Julie Tinat, Anne‐Paule Gimenez‐Roqueplo, Patrick R. Benusiglio, Sophie Lejeune‐Dumoulin et al.
European Journal of Medical Genetics
Renal cell carcinoma treatment
article

French recommendations on multi-gene panel testing in renal cell carcinoma

Julie Tinat, Anne‐Paule Gimenez‐Roqueplo, Patrick R. Benusiglio, Sophie Lejeune‐Dumoulin, Sophie Dussart, Louise Crivelli, Caroline Abadie, Jessica Moretta, Pierre Devulder, Olivier Caron, Richard J. Kahnoski, Nelly Burnichon, A. de Pauw, Nadine Andrieu, Marie Müller, Pascaline Berthet, Sophie Giraud, Isabelle Coupier, Valérie Bonadona, Catherine Noguès, Carole Corsini, Capucine Delnatte
article en

Abstract

Unlike hereditary predisposition to breast or colon cancer, hereditary renal cancer predispositions are rare syndromes and risk estimates are lacking for most of them. Prospective studies are needed to improve our knowledge. The GGC-PREDIR experts retained 12 genes for inclusion in the NGS MGP for renal cancer patients. However, the panel will be expanded on the basis of regularly updated data from the medical literature.

European Journal of Medical GeneticsVol. 78
Université Claude Bernard Lyon 1 (FR), Délégation Paris 5 (FR), Centre National de la Recherche Scientifique (FR), Inserm (FR), École Pratique des Hautes Études (FR), Université Paris Cité (FR), Université Paris Sciences et Lettres (FR), Institut Gustave Roussy (FR), Centre Hospitalier Universitaire de Bordeaux (FR), Centre Hospitalier Universitaire de Lille (FR), Sorbonne Université (FR), Centre de Recherche des Cordeliers (FR), Assistance Publique – Hôpitaux de Paris (FR), Institut de Cancérologie de Lorraine (FR), Centre François Baclesse (LU), Centre Léon Bérard (FR), Institut de Cancérologie de l'Ouest (FR), Centre Eugène Marquis (FR), Hôpital Pellegrin (FR), Pitié-Salpêtrière Hospital (FR), Centre François Baclesse (FR), Institut Bergonié (FR), Laboratoire de Biométrie et Biologie Evolutive (FR), Institut de Recherche en Cancérologie de Montpellier (FR), Centre de Recherche en Cancérologie de Marseille (FR), Hôpital Arnaud de Villeneuve (FR), Institut Paoli-Calmettes (FR), Institut de Recherche pour le Développement (FR), Institut Curie (FR)
Openalex Percentile: Top 49%
Renal cell carcinoma treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.